Cargando…

The Genetic Analysis of Cystic Fibrosis Patients with Seven Novel Mutations in the CFTR Gene in the Central Anatolian Region of Turkey

BACKGROUND: Cystic fibrosis, a pulmonary disease which is an autosomal recessive, inherited, multisystemic genetic disease commonly seen in the Caucasian race, is the most frequent cause of mortality and morbidity. So far, more than 2000 disease-causing gene variants have been found and this number...

Descripción completa

Detalles Bibliográficos
Autores principales: Erdoğan, Murat, Köse, Mehmet, Pekcan, Sevgi, Hangül, Melih, Balta, Burhan, Kiraz, Aslıhan, Akıncı Gönen, Gizem, Gül Zamani, Ayşe, Selman Yıldırım, Mahmut, Ramaslı Gürsoy, Tuğba, Ezgu, Fatih, Şişmanlar Eyüpoğlu, Tuğba, Tana Aslan, Ayse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Trakya University School of Medicine 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880976/
https://www.ncbi.nlm.nih.gov/pubmed/34860163
http://dx.doi.org/10.5152/balkanmedj.2021.21199
_version_ 1784659365374984192
author Erdoğan, Murat
Köse, Mehmet
Pekcan, Sevgi
Hangül, Melih
Balta, Burhan
Kiraz, Aslıhan
Akıncı Gönen, Gizem
Gül Zamani, Ayşe
Selman Yıldırım, Mahmut
Ramaslı Gürsoy, Tuğba
Ezgu, Fatih
Şişmanlar Eyüpoğlu, Tuğba
Tana Aslan, Ayse
author_facet Erdoğan, Murat
Köse, Mehmet
Pekcan, Sevgi
Hangül, Melih
Balta, Burhan
Kiraz, Aslıhan
Akıncı Gönen, Gizem
Gül Zamani, Ayşe
Selman Yıldırım, Mahmut
Ramaslı Gürsoy, Tuğba
Ezgu, Fatih
Şişmanlar Eyüpoğlu, Tuğba
Tana Aslan, Ayse
author_sort Erdoğan, Murat
collection PubMed
description BACKGROUND: Cystic fibrosis, a pulmonary disease which is an autosomal recessive, inherited, multisystemic genetic disease commonly seen in the Caucasian race, is the most frequent cause of mortality and morbidity. So far, more than 2000 disease-causing gene variants have been found and this number has been increasing with the studies conducted. Although there is not yet enough data that include the Turkish population, the recent increase of studies is noteworthy. AIMS: To discover the genetic variation in patients diagnosed with cystic fibrosis in the Central Anatolian region. STUDY DESIGN: Cross-sectional study. METHODS: The study was carried out in the Central Anatolian region in 3 pediatric pulmonology departments (Kayseri, Konya, and Ankara) in Turkey between July 2014 and December 2017. The Sanger and Next Generation Sequence analyses were used for exon and exon–intron boundaries in the cystic fibrosis transmembrane conductance regulatory (CFTR) gene, and in selected patients, mutation analysis was performed using the Multiplex Ligation-dependent Probe Amplification technique for large deletions and duplications. RESULTS: CFTR gene analysis was performed for 316 patients and 215 of them were genetically diagnosed with cystic fibrosis. Sixty-three different variants were defined in these patients and 7 of these were large deletions/duplications detected with the MLPA method. The most frequent variants were F508del (29.6%), G85E (8.2%), N1303K (8.2%), Y515* (7.5%), and G542* (3.4%). CONCLUSION: Using sequencing and Multiplex Ligation-dependent Probe Amplification methods, the identification of seven new mutations that were not previously reported in the literature contributes to a better understanding of the heterogeneous nature of CFTR mutations in the Turkish population. When no mutations are detected (pathogenic/probably pathogenic) in clinically compatible cases, Multiplex Ligation-dependent Probe Amplification analysis contributes significantly to the diagnosis.
format Online
Article
Text
id pubmed-8880976
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Trakya University School of Medicine
record_format MEDLINE/PubMed
spelling pubmed-88809762022-03-10 The Genetic Analysis of Cystic Fibrosis Patients with Seven Novel Mutations in the CFTR Gene in the Central Anatolian Region of Turkey Erdoğan, Murat Köse, Mehmet Pekcan, Sevgi Hangül, Melih Balta, Burhan Kiraz, Aslıhan Akıncı Gönen, Gizem Gül Zamani, Ayşe Selman Yıldırım, Mahmut Ramaslı Gürsoy, Tuğba Ezgu, Fatih Şişmanlar Eyüpoğlu, Tuğba Tana Aslan, Ayse Balkan Med J Original Article BACKGROUND: Cystic fibrosis, a pulmonary disease which is an autosomal recessive, inherited, multisystemic genetic disease commonly seen in the Caucasian race, is the most frequent cause of mortality and morbidity. So far, more than 2000 disease-causing gene variants have been found and this number has been increasing with the studies conducted. Although there is not yet enough data that include the Turkish population, the recent increase of studies is noteworthy. AIMS: To discover the genetic variation in patients diagnosed with cystic fibrosis in the Central Anatolian region. STUDY DESIGN: Cross-sectional study. METHODS: The study was carried out in the Central Anatolian region in 3 pediatric pulmonology departments (Kayseri, Konya, and Ankara) in Turkey between July 2014 and December 2017. The Sanger and Next Generation Sequence analyses were used for exon and exon–intron boundaries in the cystic fibrosis transmembrane conductance regulatory (CFTR) gene, and in selected patients, mutation analysis was performed using the Multiplex Ligation-dependent Probe Amplification technique for large deletions and duplications. RESULTS: CFTR gene analysis was performed for 316 patients and 215 of them were genetically diagnosed with cystic fibrosis. Sixty-three different variants were defined in these patients and 7 of these were large deletions/duplications detected with the MLPA method. The most frequent variants were F508del (29.6%), G85E (8.2%), N1303K (8.2%), Y515* (7.5%), and G542* (3.4%). CONCLUSION: Using sequencing and Multiplex Ligation-dependent Probe Amplification methods, the identification of seven new mutations that were not previously reported in the literature contributes to a better understanding of the heterogeneous nature of CFTR mutations in the Turkish population. When no mutations are detected (pathogenic/probably pathogenic) in clinically compatible cases, Multiplex Ligation-dependent Probe Amplification analysis contributes significantly to the diagnosis. Trakya University School of Medicine 2021-11-01 /pmc/articles/PMC8880976/ /pubmed/34860163 http://dx.doi.org/10.5152/balkanmedj.2021.21199 Text en © Copyright 2021 authors https://creativecommons.org/licenses/by-nc-nd/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Original Article
Erdoğan, Murat
Köse, Mehmet
Pekcan, Sevgi
Hangül, Melih
Balta, Burhan
Kiraz, Aslıhan
Akıncı Gönen, Gizem
Gül Zamani, Ayşe
Selman Yıldırım, Mahmut
Ramaslı Gürsoy, Tuğba
Ezgu, Fatih
Şişmanlar Eyüpoğlu, Tuğba
Tana Aslan, Ayse
The Genetic Analysis of Cystic Fibrosis Patients with Seven Novel Mutations in the CFTR Gene in the Central Anatolian Region of Turkey
title The Genetic Analysis of Cystic Fibrosis Patients with Seven Novel Mutations in the CFTR Gene in the Central Anatolian Region of Turkey
title_full The Genetic Analysis of Cystic Fibrosis Patients with Seven Novel Mutations in the CFTR Gene in the Central Anatolian Region of Turkey
title_fullStr The Genetic Analysis of Cystic Fibrosis Patients with Seven Novel Mutations in the CFTR Gene in the Central Anatolian Region of Turkey
title_full_unstemmed The Genetic Analysis of Cystic Fibrosis Patients with Seven Novel Mutations in the CFTR Gene in the Central Anatolian Region of Turkey
title_short The Genetic Analysis of Cystic Fibrosis Patients with Seven Novel Mutations in the CFTR Gene in the Central Anatolian Region of Turkey
title_sort genetic analysis of cystic fibrosis patients with seven novel mutations in the cftr gene in the central anatolian region of turkey
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880976/
https://www.ncbi.nlm.nih.gov/pubmed/34860163
http://dx.doi.org/10.5152/balkanmedj.2021.21199
work_keys_str_mv AT erdoganmurat thegeneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT kosemehmet thegeneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT pekcansevgi thegeneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT hangulmelih thegeneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT baltaburhan thegeneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT kirazaslıhan thegeneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT akıncıgonengizem thegeneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT gulzamaniayse thegeneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT selmanyıldırımmahmut thegeneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT ramaslıgursoytugba thegeneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT ezgufatih thegeneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT sismanlareyupoglutugba thegeneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT tanaaslanayse thegeneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT erdoganmurat geneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT kosemehmet geneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT pekcansevgi geneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT hangulmelih geneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT baltaburhan geneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT kirazaslıhan geneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT akıncıgonengizem geneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT gulzamaniayse geneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT selmanyıldırımmahmut geneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT ramaslıgursoytugba geneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT ezgufatih geneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT sismanlareyupoglutugba geneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey
AT tanaaslanayse geneticanalysisofcysticfibrosispatientswithsevennovelmutationsinthecftrgeneinthecentralanatolianregionofturkey